Meric-Bernstam F, Yuca E, Evans KW, Zhao M, et al. Anti-tumor activity and biomarker analysis for TROP2-antibody drug conjugate Datopotamab deruxtecan in patient-derived breast cancer xenograft models. Clin Cancer Res 2024 Nov 25. doi: 10.1158/1078-0432.CCR-24-1948.
PMID: 39585341